Download PDF
J Neurol Surg A Cent Eur Neurosurg 2018; 79(02): 130-138
DOI: 10.1055/s-0037-1606354
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Deep Brain Stimulation in Patients with Parkinson's Disease: Effect on Psychiatric Symptoms and Quality of Life

Elisa Seijo Zazo
1   Psychiatry Department, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
,
Fernando Seijo Fernandez
2   Neurosurgery Department, Medical Center of Asturias, Oviedo, Spain
,
Elena Santamarta Liebana
3   Radiology Department, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
,
Antonio Saiz Ayala
3   Radiology Department, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
,
Beatriz Lozano Aragoneses
4   Neurophysiology Department, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
,
Jose Maria Torres Campa
2   Neurosurgery Department, Medical Center of Asturias, Oviedo, Spain
,
Paz Garcia Portilla
5   Psychiatry Department, Medical Center of Asturias, Oviedo, Spain
,
Marco Alvarez Vega
6   Department of Neurosurgery, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
› Author Affiliations
Further Information

Publication History

06 December 2016

27 June 2017

Publication Date:
29 September 2017 (online)

Also available at
    Permissions and Reprints

Abstract

Background and Study Aims To determine the effect on psychiatric symptoms and quality of life in 30 patients with Parkinson's disease (PD) treated with deep brain stimulation (DBS) of both subthalamic nuclei (STN) after 1 year of follow-up.

Material and Method We conducted a prospective 1-year follow-up study with a baseline assessment before and 6 and 12 months after surgery. The following were used as assessment instruments: the Bech-Rafaelsen Melancholia Scale (MES), the Bech-Rafaelsen Mania Scale (MAS), the Beck Scale for Suicidal Ideation (SSI), the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), the Oviedo Sleep Questionnaire (OSQ), the 36-Item Short Form Health Survey (SF-36), the Unified Parkinson's Disease Rating Scale (UPDRS), the dose of levodopa, and the active contact stereotactic coordinates.

Results We recorded a clinical improvement between baseline with medication use (ON medication) and the results obtained at 6 and 12 months with medication use and stimulation (ON stimulation, ON medication) in MES and OSQ (p < 0.0001) and in SF-36 (p < 0.005). No changes were observed in MAS and SSI. There was a clinical improvement between baseline with ON medication and the results obtained at 12 months with ON stimulation, ON medication in Y-BOCS (p < 0.04). Also, there was a 53.3% reduction in levodopa at 6 months and a 54.7% reduction at 12 months after surgery (p < 0.0001). There was an improvement between baseline with OFF medication and the results obtained at 6 and 12 months OFF medication, ON stimulation (p < 0.0001) in UPDRS-III. There were no statistically significant differences between the initial and final active contact coordinates, or between stimulation parameters.

Conclusions DBS of the STN in patients with PD is associated with an improvement in psychiatric (affective and sleep-wake cycle) symptoms, clinical motor symptoms, and quality of life at 1 year after surgery.

Keywords

Parkinson's disease - psychiatric symptoms - quality of life - deep brain stimulation
 

  • References

  • 1 Schoenberg BS. Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation. Adv Neurol 1987; 45: 277-283
    PubMedGoogle Scholar
  • 2 Bonnet AM, Jutras MF, Czernecki V, Corvol JC, Vidailhet M. Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis 2012; 2012: 198316
    PubMedGoogle Scholar
  • 3 Aarsland D, Pedersen KF, Ehrt U, Bronnick K, Gjerstad MD, Larsen JP. Neuropsychiatric and cognitive symptoms in Parkinson disease [in Norwegian]. Tidsskr Nor Laegeforen 2008; 128 (18) 2072-2076
    PubMedGoogle Scholar
  • 4 Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009; 24 (15) 2175-2186
    CrossrefPubMedGoogle Scholar
  • 5 Weaver FM, Follett K, Stern M. , et al; CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301 (01) 63-73
    CrossrefPubMedGoogle Scholar
  • 6 Deuschl G, Schüpbach M, Knudsen K. , et al. Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat Disord 2013; 19 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 7 Ferreira JJ, Katzenschlager R, Bloem BR. , et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol 2013; 20 (01) 5-15
    CrossrefPubMedGoogle Scholar
  • 8 Odin P, Ray Chaudhuri K, Slevin JT. , et al; National Steering Committees. Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: consensus from an international survey and discussion program. Parkinsonism Relat Disord 2015; 21 (10) 1133-1144
    CrossrefPubMedGoogle Scholar
  • 9 Carron R, Chabardès S, Hammond C. Mechanisms of action of high-frequency deep brain stimulation. A review of the literature and current concepts. Neurochirurgie 2012; 58 (04) 209-217
    CrossrefPubMedGoogle Scholar
  • 10 Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5 (07) 578-588
    CrossrefPubMedGoogle Scholar
  • 11 Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12 (05) 265-272
    CrossrefPubMedGoogle Scholar
  • 12 Voon V, Krack P, Lang AE. , et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008; 131 (Pt 10): 2720-2728
    CrossrefPubMedGoogle Scholar
  • 13 Witt K, Daniels C, Volkmann J. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson's disease. Parkinsonism Relat Disord 2012; 18 (Suppl. 01) S168-S170
    PubMedGoogle Scholar
  • 14 Seijo F, Alvarez de Eulate Beramendi S, Santamarta Liébana E. , et al. Surgical adverse events of deep brain stimulation in the subthalamic nucleus of patients with Parkinson's disease. The learning curve and the pitfalls. Acta Neurochir (Wien) 2014; 156 (08) 1505-1512 ; discussion 1512
    CrossrefPubMedGoogle Scholar
  • 15 Bech P, Rafaelsen OJ. The use of rating scales exemplified by a comparison of the Hamilton and the Bech-Rafaelsen Melancholia Scale. Acta Psychiatr Scand 1980; 62 (S285): 128-132
    CrossrefPubMedGoogle Scholar
  • 16 Bech P, Rafaelsen OJ, Kramp P, Bolwig TG. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978; 17 (06) 430-431
    CrossrefPubMedGoogle Scholar
  • 17 Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979; 47 (02) 343-352
    CrossrefPubMedGoogle Scholar
  • 18 Goodman WK, Price LH, Rasmussen SA. , et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46 (11) 1006-1011
    CrossrefPubMedGoogle Scholar
  • 19 Bobes J, González MP, Sáiz PA. , et al. Propiedades psicométricas del cuestionario oviedo de sueño. Psicothema 2000; 12: 107-112
    PubMedGoogle Scholar
  • 20 Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30 (06) 473-483
    CrossrefPubMedGoogle Scholar
  • 21 Fahn S, Elton RL. & UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M. , eds. Recent Developments in Parkinson's Disease. Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987: 153-164 , 293–304
    Google Scholar
  • 22 Seijo F, Saiz A, Lozano B. , et al. Neuromodulation of the posterolateral hypothalamus for the treatment of chronic refractory cluster headache: Experience in five patients with a modified anatomical target. Cephalalgia 2011; 31 (16) 1634-1641
    CrossrefPubMedGoogle Scholar
  • 23 Manual de Codificación. CIE 10 ES Diagnósticos. Unidad Técnica de Codificación CIE 10 ES. Madrid, Spain: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2016
    Google Scholar
  • 24 DSM IV TR. Manual Diagnóstico y Estadístico de los Trastornos Mentales. Barcelona, Spain: Masson; 2001: 1088
    Google Scholar
  • 25 Burkhard PR, Vingerhoets FJ, Berney A, Bogousslavsky J, Villemure JG, Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 2004; 63 (11) 2170-2172
    CrossrefPubMedGoogle Scholar
  • 26 Doshi PK, Chhaya N, Bhatt MH. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 2002; 17 (05) 1084-1085
    CrossrefPubMedGoogle Scholar
  • 27 Funkiewiez A, Ardouin C, Caputo E. , et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75 (06) 834-839
    CrossrefPubMedGoogle Scholar
  • 28 Houeto JL, Mallet L, Mesnage V. , et al. Subthalamic stimulation in Parkinson disease: behavior and social adaptation. Arch Neurol 2006; 63 (08) 1090-1095
    CrossrefPubMedGoogle Scholar
  • 29 Volkmann J, Daniels C, Witt K. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol 2010; 6 (09) 487-498
    CrossrefPubMedGoogle Scholar
  • 30 Jaafari N, Giré P, Houeto JL. Deep brain stimulation, Parkinson's disease and neuropsychiatric complications [in French]. Presse Med 2009; 38 (09) 1335-1342
    CrossrefPubMedGoogle Scholar
  • 31 Bronstein JM, Tagliati M, Alterman RL. , et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68 (02) 165
    PubMedGoogle Scholar
  • 32 Follett KA, Weaver FM, Stern M. , et al; CSP 468 Study Group. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362 (22) 2077-2091
    CrossrefPubMedGoogle Scholar
  • 33 Gan J, Xie-Brustolin J, Mertens P. , et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up. J Neurol 2007; 254 (01) 99-106
    CrossrefPubMedGoogle Scholar
  • 34 Okun MS, Fernandez HH, Wu SS. , et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65 (05) 586-595
    CrossrefPubMedGoogle Scholar
  • 35 Voon V, Kubu C, Krack P, Houeto JL, Tröster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21 (Suppl. 14) S305-S327
    CrossrefPubMedGoogle Scholar
  • 36 Chopra A, Tye SJ, Lee KH. , et al. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci 2012; 24 (01) 102-110
    CrossrefPubMedGoogle Scholar
  • 37 Shon YM, Lee KH, Goerss SJ. , et al. High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery. Neurosci Lett 2010; 475 (03) 136-140
    CrossrefPubMedGoogle Scholar
  • 38 Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience. Mov Disord 2007; 22 (12) 1722-1728
    CrossrefPubMedGoogle Scholar
  • 39 Woods SP, Fields JA, Tröster AI. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review. Neuropsychol Rev 2002; 12 (02) 111-126
    CrossrefPubMedGoogle Scholar
  • 40 Lilleeng B, Dietrichs E. Unmasking psychiatric symptoms after STN deep brain stimulation in Parkinson's disease. Acta Neurol Scand Suppl 2008; 188: 41-45
    PubMedGoogle Scholar
  • 41 Alegret M, Junqué C, Valldeoriola F, Vendrell P, Martí MJ, Tolosa E. Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70 (03) 394-396
    CrossrefPubMedGoogle Scholar
  • 42 Fontaine D, Mattei V, Borg M. , et al. Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report. J Neurosurg 2004; 100 (06) 1084-1086
    CrossrefPubMedGoogle Scholar
  • 43 Kopell BH, Greenberg B, Rezai AR. Deep brain stimulation for psychiatric disorders. J Clin Neurophysiol 2004; 21 (01) 51-67
    CrossrefPubMedGoogle Scholar
  • 44 Mallet L, Mesnage V, Houeto JL. , et al. Compulsions, Parkinson's disease, and stimulation. Lancet 2002; 360 (9342): 1302-1304
    CrossrefPubMedGoogle Scholar
  • 45 Antonini A, Landi A, Mariani C, DeNotaris R, Pezzoli G. Deep brain stimulation and its effect on sleep in Parkinson's disease. Sleep Med 2004; 5 (02) 211-214
    CrossrefPubMedGoogle Scholar
  • 46 Hjort N, Østergaard K, Dupont E. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004; 19 (02) 196-199
    CrossrefPubMedGoogle Scholar
  • 47 Mehta SH, Morgan JC, Sethi KD. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment. CNS Spectr 2008; 13 (03) (Suppl. 04) 6-11
    PubMedGoogle Scholar
  • 48 Li D, Cao C, Zhang J, Zhan S, Chen S, Sun B. Subthalamic nucleus deep brain stimulation for Parkinson's disease: 8 years of follow-up. Transl Neurodegener 2013; 2 (01) 11
    CrossrefPubMedGoogle Scholar
  • 49 Lyons KE, Pahwa R. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg 2005; 103 (02) 252-255
    CrossrefPubMedGoogle Scholar
  • 50 Daniels C, Krack P, Volkmann J. , et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?. Mov Disord 2011; 26 (14) 2516-2521
    CrossrefPubMedGoogle Scholar
  • 51 Wang X, Chang C, Geng N. , et al. Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (08) 587-591
    CrossrefPubMedGoogle Scholar
  • 52 Funkiewiez A, Ardouin C, Krack P. , et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord 2003; 18 (05) 524-530
    CrossrefPubMedGoogle Scholar
  • 53 Kleiner-Fisman G, Herzog J, Fisman DN. , et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 (Suppl. 14) S290-S304
    CrossrefPubMedGoogle Scholar
  • 54 Wodarg F, Herzog J, Reese R. , et al. Stimulation site within the MRI-defined STN predicts postoperative motor outcome. Mov Disord 2012; 27 (07) 874-879
    CrossrefPubMedGoogle Scholar
  • 55 Welter ML, Schüpbach M, Czernecki V. , et al. Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology 2014; 82 (15) 1352-1361
    CrossrefPubMedGoogle Scholar
  • 56 Geevarghese R, O'Gorman Tuura R, Lumsden DE, Samuel M, Ashkan K. Registration accuracy of CT/MRI fusion for localisation of deep brain stimulation electrode position: an imaging study and systematic review. Stereotact Funct Neurosurg 2016; 94 (03) 159-163
    CrossrefPubMedGoogle Scholar
  • 57 Paek SH, Yun JY, Song SW. , et al. The clinical impact of precise electrode positioning in STN DBS on three-year outcomes. J Neurol Sci 2013; 327 (1–2): 25-31
    CrossrefPubMedGoogle Scholar
  • 58 Kondziolka D, Dempsey PK, Lunsford LD. , et al. A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination. Neurosurgery 1992; 30 (03) 402-406 ; discussion 406–407
    CrossrefPubMedGoogle Scholar
  • 59 O'Gorman RL, Jarosz JM, Samuel M, Clough C, Selway RP, Ashkan K. CT/MR image fusion in the postoperative assessment of electrodes implanted for deep brain stimulation. Stereotact Funct Neurosurg 2009; 87 (04) 205-210
    CrossrefPubMedGoogle Scholar
  • 60 Thani NB, Bala A, Swann GB, Lind CR. Accuracy of postoperative computed tomography and magnetic resonance image fusion for assessing deep brain stimulation electrodes. Neurosurgery 2011; 69 (01) 207-214 ; discussion 214
    CrossrefPubMedGoogle Scholar
  • 61 Schaltenbrand G, Warren W. Atlas for Stereotaxy of the Human Brain. Stuttgart, Germany: Thieme; 1977
    Google Scholar
  • 62 Godinho F, Thobois S, Magnin M. , et al. Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts. J Neurol 2006; 253 (10) 1347-1355
    CrossrefPubMedGoogle Scholar
  • 63 Hamel W, Fietzek U, Morsnowski A. , et al. Subthalamic nucleus stimulation in Parkinson's disease: correlation of active electrode contacts with intraoperative microrecordings. Stereotact Funct Neurosurg 2003; 80 (1–4): 37-42
    CrossrefPubMedGoogle Scholar
  • 64 Voges J, Volkmann J, Allert N. , et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg 2002; 96 (02) 269-279
    CrossrefPubMedGoogle Scholar
  • 65 Weise LM, Seifried C, Eibach S. , et al. Correlation of active contact positions with the electrophysiological and anatomical subdivisions of the subthalamic nucleus in deep brain stimulation. Stereotact Funct Neurosurg 2013; 91 (05) 298-305
    CrossrefPubMedGoogle Scholar
  • 66 Salvador-Aguiar C, Menéndez-Guisasola L, Blázquez-Estrada M, Fernández-González F, Seijo-Fernández F. Psychiatric symptoms of Parkinson's disease following deep brain stimulation surgery on the subthalamic nucleus [in Spanish]. Rev Neurol 2004; 39 (07) 651-655
    PubMedGoogle Scholar
  • 67 Frankemolle AM, Wu J, Noecker AM. , et al. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming. Brain 2010; 133 (Pt 3): 746-761
    CrossrefPubMedGoogle Scholar
  • 68 Lalys F, Haegelen C, Mehri M, Drapier S, Vérin M, Jannin P. Anatomo-clinical atlases correlate clinical data and electrode contact coordinates: application to subthalamic deep brain stimulation. J Neurosci Methods 2013; 212 (02) 297-307
    CrossrefPubMedGoogle Scholar
  • 69 Eisenstein SA, Koller JM, Black KD. , et al. Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. Ann Neurol 2014; 76 (02) 279-295
    CrossrefPubMedGoogle Scholar
  • 70 Aviles-Olmos I, Kefalopoulou Z, Tripoliti E. , et al. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach. J Neurol Neurosurg Psychiatry 2014; 85 (12) 1419-1425
    CrossrefPubMedGoogle Scholar
  • 71 Zaidel A, Spivak A, Grieb B, Bergman H, Israel Z. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease. Brain 2010; 133 (Pt 7): 2007-2021
    CrossrefPubMedGoogle Scholar
  • 72 Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization. J Neurosurg 2016; 125 (05) 1068-1079
    CrossrefPubMedGoogle Scholar
  • 73 Abulseoud OA, Kasasbeh A, Min HK. , et al. Stimulation-induced transient nonmotor psychiatric symptoms following subthalamic deep brain stimulation in patients with Parkinson's disease: association with clinical outcomes and neuroanatomical correlates. Stereotact Funct Neurosurg 2016; 94 (02) 93-101
    CrossrefPubMedGoogle Scholar
  • 74 Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318 (5854): 1309-1312
    CrossrefPubMedGoogle Scholar
  • 75 Cozac VV, Ehrensperger MM, Gschwandtner U. , et al. Older candidates for subthalamic deep brain stimulation in Parkinson's disease have a higher incidence of psychiatric serious adverse events. Front Aging Neurosci 2016; 8: 132
    PubMedGoogle Scholar
  • 76 Schuepbach Wm, Rau J, Knudsen K. , et al. Neurostimulation for Parkinson's diseases with early motor complications. N Engl J Med 2013; 368 (07) 610-622
    CrossrefPubMedGoogle Scholar